“There is no way we will be distracted by large-scale M&A going on in the sector,” Witty said on a conference call with reporters. “Nothing that has happened in the past month has changed my view on this. You will see us make acquisitions but they will be small- to medium-size and will not be a mega- merger.”
Mas...Reports had suggested that the firm would cut as many as 10,000 posts.
Tomé "prestado" de PharmaGossip
No hay comentarios:
Publicar un comentario